MARKET

LBRX

LBRX

LB Pharmaceuticals
NASDAQ
19.50
+0.25
+1.30%
After Hours: 19.50 0 0.00% 16:00 12/05 EST
OPEN
19.21
PREV CLOSE
19.25
HIGH
20.34
LOW
19.21
VOLUME
227.41K
TURNOVER
--
52 WEEK HIGH
20.34
52 WEEK LOW
13.36
MARKET CAP
391.95M
P/E (TTM)
-138.6913
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LBRX last week (1124-1128)?
Weekly Report · 4d ago
USA Rare Earth, Firefly Aerospace in FTSE Russell Preliminary List of IPO Additions
Seeking Alpha · 11/26 12:43
LB PHARMACEUTICALS ANNOUNCES PRESENTATION AT THE PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE
Reuters · 11/24 13:00
Weekly Report: what happened at LBRX last week (1117-1121)?
Weekly Report · 11/24 09:55
LB Pharmaceuticals Inc. Files Initial Beneficial Ownership Statement for Chief Commercial Officer Kaya Kamlesh Pai Panandiker
Reuters · 11/18 23:58
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday
Benzinga · 11/17 16:39
Weekly Report: what happened at LBRX last week (1110-1114)?
Weekly Report · 11/17 09:55
LB Pharmaceuticals Expands Lease at One Penn Plaza
TipRanks · 11/13 13:49
More
About LBRX
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. The Company is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a Phase III-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The Company is also developing a long-acting injectable, or LAI, formulation of LB-102, which improves compliance, a common issue in patients with schizophrenia and bipolar disorder.

Webull offers LB Pharmaceuticals Inc stock information, including NASDAQ: LBRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LBRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LBRX stock methods without spending real money on the virtual paper trading platform.